ArticleFrontiers in immunology2019
Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.
- Variants in complement genes are uncommon in patients with anti-factor H autoantibody-associated atypical hemolytic uremic syndrome.Pediatric nephrology (Berlin, Germany) · 2023Pooled it
- Systematic review of atypical hemolytic uremic syndrome biomarkers.Pediatric nephrology (Berlin, Germany) · 2022Pooled it
- IPNA clinical practice recommendations for the management of aHUS and secondary TMA in children.Pediatric nephrology (Berlin, Germany) · 2026Article
- Renal-Limited Thrombotic Microangiopathy in Infants: A Case Series.Kidney medicine · 2026Article
- Incidence and severity of extrarenal manifestations and outcomes in pediatric hemolytic uremic syndrome: a retrospective cohort study.Pediatric nephrology (Berlin, Germany) · 2026Article
- A systematic review of short-term outcomes in patients with anti-factor H associated atypical HUS managed with plasma exchanges versus eculizumab.Pediatric nephrology (Berlin, Germany) · 2026Review
- Complement diagnostics and therapeutics for the pediatric population: early successes and opportunities for further advancement.Frontiers in pharmacology · 2026Review
- Indications and recent evidence for apheresis in children and adults with kidney diseases: a comprehensive review.Clinical kidney journal · 2025Review
- Comprehensive genetic analysis and genotype-phenotype correlations in pediatric patients with atypical hemolytic uremic syndrome.Pediatric nephrology (Berlin, Germany) · 2025Article
- Short-Term Efficacy of Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome.Indian journal of pediatrics · 2025Article
- Atypical Hemolytic Uremic Syndrome: A Review of Complement Dysregulation, Genetic Susceptibility and Multiorgan Involvement.Journal of clinical medicine · 2025Review
- Eculizumab as first-line treatment for patients with severe presentation of complement factor H antibody-mediated hemolytic uremic syndrome.Pediatric nephrology (Berlin, Germany) · 2025Article
- Autoantibodies Against Factor B and Factor H Without Pathogenic Effects in a Patient with Immune Complex-Mediated Membranoproliferative Glomerulonephritis.Biomedicines · 2025Article
- Complement-mediated HUS revisited: evolving insights into pathophysiology, diagnosis, and treatment.Frontiers in immunology · 2025Review
- Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy.Hematology. American Society of Hematology. Education Program · 2024Review
- Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum.Kidney international · 2024Article
- Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?Pediatric nephrology (Berlin, Germany) · 2024Article
- Managing anti-factor H antibody-associated hemolytic uremic syndrome: time for consensus.Pediatric nephrology (Berlin, Germany) · 2024Article
- Abbreviated protocol of plasma exchanges for patients with anti-factor H associated hemolytic uremic syndrome.Pediatric nephrology (Berlin, Germany) · 2024Article
- Anti-factor B antibodies in atypical hemolytic uremic syndrome.Pediatric nephrology (Berlin, Germany) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 10 institutions in 1 country.
Mamta PuraswaniDivision of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Priyanka KhandelwalDivision of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Himanshi SainiDivision of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Savita SainiDivision of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Bahadur Singh GurjarImmuno Biology Laboratory II, National Institute of Immunology, New Delhi, India.
Aditi SinhaDivision of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Rajashri Pramod ShendeNational Centre for Cell Science, Pune, India.
Tushar Kanti MaitiRegional Center for Biotechnology, Faridabad, India.
Abhishek Kumar SinghRegional Center for Biotechnology, Faridabad, India.
Uma KangaDepartment of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.
Uma AliDepartment of Pediatrics, BJ Wadia Hospital for Children, Mumbai, India.
Indira AgarwalDepartment of Pediatrics, Christian Medical College, Vellore, India.
Kanav AnandDivision of Pediatric Nephrology, Sir Ganga Ram Hospital, New Delhi, India.
Narayan PrasadDepartment of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Padmaraj RajendranDepartment of Pediatric Nephrology, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai, India.
Rajiv SinhaDepartment of Pediatrics, Institute of Child Health, Kolkata, India.
Anil VasudevanDepartment of Pediatric Nephrology, St. Johns Medical College and Hospital, Bengaluru, India.
Anita SaxenaDepartment of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Sanjay AgarwalDepartment of Nephrology, All India Institute of Medical Sciences, New Delhi, India.
Pankaj HariDivision of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Arvind SahuNational Centre for Cell Science, Pune, India.
Satyajit RathNational Centre for Cell Science, Pune, India.
Arvind BaggaDivision of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
All India Institute of Medical Sciences · INNational Centre for Cell Science · INInstitute of Child Health · INRegional Centre for Biotechnology · INBai Jerbai Wadia Hospital for Children · INChristian Medical College & Hospital · INNational Institute of Immunology · INSanjay Gandhi Post Graduate Institute of Medical Sciences · INSir Ganga Ram Hospital · INSt.John's Medical College Hospital · IN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdolescentAtypical Hemolytic Uremic SyndromeAutoantibodiesAutoantigensChildChild, PreschoolComplement Factor HDatabases, FactualFemaleHumansImmunosuppressive AgentsInfantMaleAutoantibodiesAutoantigensCFH protein, humanComplement Factor HImmunosuppressive Agentsatypical hemolytic uremic syndromefactor Hplasma exchangerenal reservethrombotic microangiopathy
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.